What will be the Trends And Forecast of Europe Cancer Diagnostics Market? Get Detail Future Insights Of Market by 2024

Data Bridge Market Research provides new industry report “Europe Cancer Diagnostics Market” is expected to reach USD 13.02 billion by 2024 from USD 5.16 billion in 2016, at a CAGR of 12.3% in the forecast period 2017 to 2024.

Get Free Sample Copy of this Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-cancer-diagnostics-market

Complete report on Europe Cancer Diagnostics Market Research Report 2017-2024 spread across 175 Pages, profiling Top companies and supports with tables and figures

Cancer is defined as a malignant growth or tumor resulting from an uncontrolled division of cells. According to Centers for Disease Control and Prevention (CDC), cancer is the second leading cause of mortality, causing approximately 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR), among others. Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market.

Key Drivers: Europe Cancer Diagnostics Market

Some of the major factors driving the market for cancer diagnostics market are rise in the aging population in European countries and government initiatives. These factors increase the demand for cancer diagnostics products. Increasing prevalence of cancer, key players focusing are on strategic decisions is the major factor driving the growth of the cancer diagnostics market.

  • Stringent regulations imposed by the international and local authorities and shortage of the skilled and trained professionals are the factors which may hinder the growth of this market.
  • Many companies are increasingly focusing on next generation sequencing (NGS) and biopsy products in order to strengthen their product portfolios in the cancer diagnostics market.
  • Increasing demand for magnetic resonance imaging (MRI) and next generation sequencing (NGS) will drive the market in future.

Customize report of “Europe Cancer Diagnostics Market” as per customers requirement also available.

For more insightful information visit@ http://databridgemarketresearch.com/reports/europe-cancer-diagnostics-market/

Some of the major players operating in this market are

  • Siemens Healthcare
  • Hologic, Inc
  • Becton
  • Dickinson and Company
  • Thermo Fisher Scientific, Inc
  • Illumina, Inc
  • Roche Diagnostics
  • Abbott Laboratories, Inc.
  • QIAGEN.

Request for Detailed TOC: http://databridgemarketresearch.com/toc/?dbmr=europe-cancer-diagnostics-market

Market Segmentations:

Europe Cancer Diagnostics Market is segmented into

  • Technology
  • Application
  • Geography

Market Segmentations in Details:

On the basis of Technology, Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

On the basis of Application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

On the basis of Geography, the Europe Cancer Diagnostics Market is segmented into:

  • Germany
  • France
  • United kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe

Key Points: Europe Cancer Diagnostics Market

  • Next Generation Sequencing (NGS) market is growing with the highest CAGR.
  • Europe biopsy is driving the market withthe highest market share.
  • Magnetic resonance imaging (MRI) is dominating the cancer diagnostics imaging market.

Inquire for the report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-cancer-diagnostics-market

Other Report

Global Active Wound Care Market– Industry Trends and Forecast to 2024

Global Active Wound Care Market By Product Type (Allograft, Synthetic Skin Grafts, Xenografts, Collagen Dressings, Amniotic Tissue Grafts, Growth Factors (Platelet Derived Growth Factor (PDGF), Platelet Rich Plasma (PRP), Epidermal Growth Factors (EGF), Basic Fibroblast Growth Factors (BFGF), Granulocyte Colony Stimulating Factor     (G-CSF), Talactoferrin ALFA, Thrombin Peptide, and Keratinocyte Growth Factor (KGF)), By Distribution Channel, By End Users, By Indication, Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-active-wound-care-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Bloghttp://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net